These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 3135739

  • 1. Electrophysiologic effects and clinical efficacy of flecainide in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Greco R.
    Am J Cardiol; 1988 Aug 01; 62(4):229-33. PubMed ID: 3135739
    [Abstract] [Full Text] [Related]

  • 2. [Electrophysiological effects and clinical efficacy of flecainide in childhood patients with supraventricular reciprocating paroxysmal tachycardia].
    Musto B, D'Onofrio A, Cavallaro C, Musto A, Della Gatta O, Marsico F.
    G Ital Cardiol; 1987 May 01; 17(5):444-9. PubMed ID: 3115857
    [Abstract] [Full Text] [Related]

  • 3. Electrophysiological effects and clinical efficacy of propafenone in children with recurrent paroxysmal supraventricular tachycardia.
    Musto B, D'Onofrio A, Cavallaro C, Musto A.
    Circulation; 1988 Oct 01; 78(4):863-9. PubMed ID: 3168194
    [Abstract] [Full Text] [Related]

  • 4. Cardiac electrophysiologic effects of flecainide acetate for paroxysmal reentrant junctional tachycardias.
    Hellestrand KJ, Nathan AW, Bexton RS, Spurrell RA, Camm AJ.
    Am J Cardiol; 1983 Mar 01; 51(5):770-6. PubMed ID: 6829436
    [Abstract] [Full Text] [Related]

  • 5. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS, Lal R, Ruffy R.
    Am J Cardiol; 1986 Jul 01; 58(1):80-5. PubMed ID: 3728336
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI, Tronstad A, Oie B, Ohm OJ.
    Am J Cardiol; 1988 Sep 15; 62(9):585-9. PubMed ID: 3137798
    [Abstract] [Full Text] [Related]

  • 7. [Role of a "bystander" concealed accessory pathway in the response to verapamil and flecainide treatment in a patient with nodal reentry tachycardia].
    Matteucci C, Busi G.
    G Ital Cardiol; 1996 Apr 15; 26(4):419-25. PubMed ID: 8707026
    [Abstract] [Full Text] [Related]

  • 8. Electrophysiologic effects of isoproterenol in patients with atrioventricular reentrant tachycardia treated with flecainide.
    Helmy I, Scheinman MM, Herre JM, Sharkey H, Griffin JC.
    J Am Coll Cardiol; 1990 Dec 15; 16(7):1649-55. PubMed ID: 2123908
    [Abstract] [Full Text] [Related]

  • 9. Electrophysiologic effects and therapeutic efficacy of intravenous flecainide for termination of paroxysmal supraventricular tachycardia.
    Gambhir DS, Bhargava M, Arora R, Khalilullah M.
    Indian Heart J; 1995 Dec 15; 47(3):237-43. PubMed ID: 7558090
    [Abstract] [Full Text] [Related]

  • 10. Comparison of the effects of intravenous and oral betaxolol on antegrade and retrograde conduction in patients with atrioventricular nodal reentrant and atrioventricular reentrant tachycardia.
    Kühlkamp V, Ickrath O, Haasis R, Seipel L.
    Eur Heart J; 1989 Jun 15; 10(6):493-501. PubMed ID: 2569398
    [Abstract] [Full Text] [Related]

  • 11. Flecainide acetate for treatment of bypass tract mediated reentrant tachycardia.
    Zee-Cheng CS, Kim SS, Ruffy R.
    Am J Cardiol; 1988 Aug 25; 62(6):23D-28D. PubMed ID: 3136631
    [Abstract] [Full Text] [Related]

  • 12. [Treatment of recurrent supraventricular tachyarrhythmias with flecainide or a flecainide and amiodarone combination].
    Purcaro A, Capestro F, Ciampani N, Fratadocchi GB, Mazzanti M, Costantini C, Molini E.
    G Ital Cardiol; 1987 Aug 25; 17(8):690-8. PubMed ID: 3121426
    [Abstract] [Full Text] [Related]

  • 13. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of long-term oral flecainide acetate in patients with responsive supraventricular tachycardia.
    Hellestrand KJ.
    Am J Cardiol; 1996 Jan 25; 77(3):83A-88A. PubMed ID: 8607396
    [Abstract] [Full Text] [Related]

  • 16. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
    Manz M, Steinbeck G, Lüderitz B.
    Am J Cardiol; 1985 Oct 01; 56(10):593-7. PubMed ID: 4050693
    [Abstract] [Full Text] [Related]

  • 17. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
    Musto B, D'Onofrio A, Musto A, Cavallaro C, Marsico F.
    G Ital Cardiol; 1986 Apr 01; 16(4):336-43. PubMed ID: 3743937
    [Abstract] [Full Text] [Related]

  • 18. Electrophysiologic effects and antiarrhythmic efficacy of recainam in patients with supraventricular tachycardia.
    Tai YT, Campbell RW, McComb JM.
    J Cardiovasc Pharmacol; 1991 Feb 01; 17(2):310-5. PubMed ID: 1709237
    [Abstract] [Full Text] [Related]

  • 19. Flecainide single oral dose for management of paroxysmal supraventricular tachycardia in children and young adults.
    Musto B, Cavallaro C, Musto A, D'Onofrio A, Belli A, De Vincentis L.
    Am Heart J; 1992 Jul 01; 124(1):110-5. PubMed ID: 1615792
    [Abstract] [Full Text] [Related]

  • 20. Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways.
    Sethi KK, Jaishankar S, Khalilullah M, Gupta MP.
    Br Heart J; 1983 Jun 01; 49(6):532-43. PubMed ID: 6849716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.